ONVO Projected Dividend Yield

Organovo Holdings Inc ( NASDAQ : ONVO )

Organovo Holdings is a biotechnology company that focuses on building 3D tissues that recapitulate primary aspects of human disease. Co. uses these models to identify gene targets responsible for driving the disease and initiates drug discovery programs around these validated targets. Co.'s NovoGen Bioprinters® are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells. Co.'s NovoGen Bioprinters® can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters. Co.'s NovoGen Bioprinters® also serve as components of its tissue prototyping and manufacturing platform.

21 YEAR PERFORMANCE RESULTS